Demand for LC–MS up, GC and LC down
The financial reports for Agilent Technologies' first quarter of 2009 have identified trends in the demand for product platforms.
The financial reports for Agilent Technologies’ first quarter of 2009 have identified trends in the demand for product platforms.
Breaking the report down by platform showed both gas and liquid chromatography systems have performed weaker than last year, while both microarrays and LC–MS grew by double digits.
Additionally, although the company reports the revenues of the company’s bio-analytical segment are down on last year’s, life science sales to academic and government markets are up dramatically, owing to particular strength in microassays and LC–MS systems shown by this sector. The food safety market also performed well.
Traditional Chinese Medicine’s Effects on Liver Cancer Measured Using New UHPLC–QTOF-MS System
April 22nd 2024Scientists from Anhui University of Chinese Medicine in Hefei, China recently investigated the mechanisms behind what makes huachansu tablets, a type of traditional Chinese medicine (TCM), effective against liver cancer.
